TNXP
#3519
Tonix Pharmaceuticals Holding Corp. - Common Stock
13.5 9 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.22%
Variación mensual
+33.76%
Variación en los últimos 6 meses
+1.87%
Cambio anual
-9.46%
Cierres anteriores
13.5 6
Open
13.5 9
Mínimo
13.5 9
Máximo
13.5 9
Volumen
37
Financials
- Market Capitalization 233.08 M
- Employee 142
- Founded 2007
- CEO Seth Lederman
- Website www.tonixpharma.com
- Headquarter Nevada, United States
- FIGI BBG000LG8XM5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.96
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3492 |  PRQR ProQR Therapeutics N.V. - Ordinary Shares | 2.29 USD | -1.29% | -2.14% | +32.37% | +2.23% | 241.28 M USD | ||
| 3517 |  RNA Atrium Therapeutics, Inc. - Common Stock | 13.64 USD | -2.43% | +2.79% | +19.13% | -80.61% | 233.32 M USD | ||
| 3529 |  NERV Minerva Neurosciences, Inc - Common Stock | 4.84 USD | -5.65% | +1.04% | +22.53% | +105.96% | 231.10 M USD | ||
| 3535 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 15.67 USD | -16.34% | -5.83% | +16.07% | +35.09% | 230.01 M USD |